Abatacept or tocilizumab after rituximab in rheumatoid arthritis? : An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 158444772
- Type
- D - Journal article
- DOI
-
10.1136/annrheumdis-2013-204417
- Title of journal
- Annals of the rheumatic diseases
- Article number
- -
- First page
- 909
- Volume
- 73
- Issue
- 5
- ISSN
- 0003-4967
- Open access status
- Out of scope for open access requirements
- Month of publication
- May
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
8
- Research group(s)
-
B - Musculoskeletal and Dermatological Sciences
- Citation count
- 29
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
